Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension

Open access
de Man, Frances S., Tu, Ly, Handoko, M. Louis, Rain, Silvia, Ruiter, Gerrina, François, Charlène, Schalij, Ingrid, Dorfmüller, Peter, Simonneau, Gérald, Fadel, Elie, Perros, Frederic, Boonstra, Anco, Postmus, Piet E., van der Velden, Jolanda, Vonk-Noordegraaf, Anton, Humbert, Marc, Eddahibi, Saadia, Guignabert, Christophe · 2012 · American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale: Patients with idiopathic pulmonary arterial hypertension (iPAH) often have a low cardiac output. To compensate, neurohormonal systems such as the renin–angiotensin–aldosterone system (RAAS) and the sympathetic nervous system are up-regulated, but this may have long-term negative effects on the progression of iPAH. Objectives: Assess systemic and pulmonary RAAS activity in patients with iPAH and determine the efficacy of chronic RAAS inhibition in experimental PAH. Methods: We collected 79 blood samples from 58 patients with iPAH in the VU University Medical Center Amsterdam (between 2004 and 2010) to determine systemic RAAS activity. Measurements and Main Results: We observed increased levels of renin, angiotensin (Ang)I, and AngII, which were associated with disease progression (P < 0.05) and mortality (P < 0.05). To determine pulmonary RAAS activity, lung specimens were obtained from patients with iPAH (during lung transplantation, n = 13) and control subjects (during lobectomy or pneumonectomy for cancer, n = 14). Local RAAS activity in pulmonary arteries of patients with iPAH was increased, demonstrated by elevated angiotensin-converting enzyme activity in pulmonary endothelial cells and increased AngII type 1 (AT1) receptor expression and signaling. In addition, local RAAS up-regulation was associated with increased pulmonary artery smooth muscle cell proliferation via enhanced AT1 receptor signaling in patients with iPAH compared with control subjects. Finally, to determine the therapeutic potential of RAAS activity, we assessed the chronic effects of an AT1 receptor antagonist (losartan) in the monocrotaline PAH rat model (60 mg/kg). Losartan delayed disease progression, decreased right ventricular afterload and pulmonary vascular remodeling, and restored right ventricular–arterial coupling in rats with PAH. Conclusions: Systemic and pulmonary RAAS activities are increased in patients with iPAH and are associated with increased pulmonary vascular remodeling. Chronic inhibition of RAAS by losartan is beneficial in experimental PAH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.201203-0411oc

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 358

Metadata

Authors
de Man, F. S., Tu, L., Handoko, M. L., Rain, S., Ruiter, G., François, C., Schalij, I., Dorfmüller, P., Simonneau, G., Fadel, E., Perros, F., Boonstra, A., Postmus, P. E., van der Velden, J., Vonk-Noordegraaf, A., Humbert, M., Eddahibi, S., & Guignabert, C.
Affiliations
  • INSERM UMR 999, LabEx LERMIT, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Université Paris-Sud (FR)
  • Amsterdam Cardiovascular Sciences (NL)
  • Department of Pulmonology and
  • Department of Physiology, VU University Medical Center/Institute of Cardiovascular Research, Amsterdam, The Netherlands; and
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2012-10
Volume
186
Issue
8
Pages
780-789
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2156240908
Cited by
346
References
39
Citations by year
2026: 12 · 2025: 10 · 2024: 16 · 2023: 25 · 2022: 21 · 2021: 42 · 2020: 33 · 2019: 25 · 2018: 29 · 2017: 16 · 2016: 21 · 2015: 34 · 2014: 26 · 2013: 28 · 2012: 7
FWCI
24.48
Type
journal article
Language
en
Open access
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
European Respiratory Society
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
Keywords
idiopathic pulmonary arterial hypertension, renin-angiotensin-aldosterone system, angiotensin II type 1 receptor, angiotensin-converting enzyme, pulmonary vascular remodeling, losartan, monocrotaline-induced pulmonary hypertension, right ventricular afterload, right ventricular-arterial coupling, disease progression, mortality, angiotensin I, angiotensin II
MeSH terms
Animals, Cells, Cultured, Endothelium, Vascular, Female, Humans, Hypertension, Pulmonary, Male, Middle Aged, Renin-Angiotensin System, Up-Regulation, Proportional Hazards Models, Case-Control Studies, Monocrotaline, Disease Progression, Losartan, Myocytes, Smooth Muscle, Receptor, Angiotensin, Type 1, Angiotensin II Type 1 Receptor Blockers, Rats, Familial Primary Pulmonary Hypertension

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension. https://app.cochat.ai/papers/10.1164/rccm.201203-0411oc
The paper
de Man, F. S., Tu, L., Handoko, M. L., Rain, S., Ruiter, G., François, C., Schalij, I., Dorfmüller, P., Simonneau, G., Fadel, E., Perros, F., Boonstra, A., Postmus, P. E., van der Velden, J., Vonk-Noordegraaf, A., Humbert, M., Eddahibi, S., & Guignabert, C. (2012). Dysregulated Renin–Angiotensin–Aldosterone System Contributes to Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.201203-0411oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.